Recombinant CD4 (Clenoliximab Biosimilar) antibody

Catalog No. ABIN7597592

This anti- antibody is a Chimeric Chimeric antibody detecting in . Suitable for Human.

Quick Overview for Recombinant CD4 (Clenoliximab Biosimilar) antibody (ABIN7597592)

Target: CD4 (Clenoliximab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Chimeric

Clonality: Chimeric

Conjugate: Un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details

Expression System: Mammalian cells

Purpose: Research Grade Clenoliximab Biosimilar Antibody

Specificity: T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 lambda

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details

Target: CD4 (Clenoliximab Biosimilar)

Alternative Name: Clenoliximab Biosimilar

Target Type: Biosimilar

Background: T-cell surface antigen T4/Leu-3, T-cell surface glycoprotein CD4, CD4

UniProt: P01730

CAS-No: 182912-58-9